DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Sandborn WJ, Ghosh S, Panes J. et al.
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease.
Clin Gastroenterol Hepatol 2014;
12: 1485-1493.e2
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.